官方服务：
资源简介：
Developing an Arg-UGA-sup-tRNA enables AAV delivery and disease-agnostic in vivo gene therapy
应用场景：
创建时间：
2025-12-03
相关数据集
Cardiac Applications of CRISPR/AAV-Mediated Precise Genome Editing. Cardiac Applications of CRISPR/AAV-Mediated Precise Genome Editing
The activity of cardiomyocyte and control enhancers was assessed in mouse cardiomyocytes, using two assay formats: a Tnni1 genomically integrated MPRA and AAV-based episomal MPRAs with various minimal
NIAID Data Ecosystem50
Leveraging Gene Therapy to Achieve Long-Term Continuous or Controllable Expression of Biotherapeutics
T cells redirected to cancer cells either via a chimeric antigen receptor or a bispecific molecule have been breakthrough technologies in cancer immunotherapy, yet each have significant limitations. H
NIAID Data Ecosystem30
Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice
The development of spontaneous autoimmune diabetes in nonobese diabetic (NOD) mice provides for their use as a model of human type 1 diabetes. To test the feasibility of muscle-directed gene therapy t
PubMed Central2001-11-20 更新20
AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice (tRNA_charging)
In this study, we utilized a mouse model of mucopolysaccharidosis type I (MPS-I) carrying a homozygous nonsense mutation in the Idua gene (Idua-W401X, TGG→TAG) to develop rAAV-delivered sup-tRNA thera
NIAID Data Ecosystem30
Latent Adeno-Associated Virus Infection Elicits Humoral but Not Cell-Mediated Immune Responses in a Nonhuman Primate Model
Latent infection with wild-type (wt) adeno-associated virus (AAV) was studied in rhesus macaques, a species that is a natural host for AAV and that has some homology to humans with respect to the pref
PubMed Central20
